JPRN-UMIN000001308已完成2 期
Safety and efficacy of preoperative chemotherapy with mFOLFOX6+Bevacizumab in patients with liver-only metastases (H2, H3) from colorectal cancer; histological assessment of liver damage from preoperative chemotherapy. - Safety and efficacy of preoperative chemotherapy with mFOLFOX6+Bevacizumab in patients with liver-only metastases (H2, H3) from colorectal cancer; histological assessment of liver damage from preoperative chemotherapy.(KSCC0802)
Kyushu Study group of Clinical Cancer0 个研究点目标入组 39 人开始时间: 2008年8月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 39
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Administering antithrobotic drug within 7 days 2. Serious drug hypersensitivity or a history of drug allergy 3. Peripheral neuropathy 4. Active concomitant malignancy 5. Active infections 6. Serious complications (renal failure or hepatic failure) 7. High blood pressure and diabetic and hypercalcemia that cannot be controlled 8. symptomatic or asymptomatic but treated heart disease 9. interstitial pnumonitis, pulmonary fibrosis or high-grade pulmonary emphysema 10. histry of mental disturbances or cerebrovascular attack 11. Fresh hemorrhage from digestive tube, intestines tube paralysis, intestinal obstruction and peptic ulcer 12. Current or previous (within one year) history of GI perforation 13. Plerral effusion, peritoneal fluid and pericardial fluid 14. Symptomatic brain metastasis 15. Water solubility diarrhea, in case of the patient who has a colostomy, diarrhea impairs daily life activity 16. under coutinuous steroid therapy 17. Any surgical treatments including skin-open biopsy, trauma surgery and other more intensive surgery within 4 weeks or aspiration biopsy within one week 18. CV-port procedure within one week 19. Anti-platelets therapy (including aspirin and NSAIDS) 20. Bleeding tendency, coagulation abnormality 21. history of organ transplantation 22. Traumatic gracture of unrecovery 23. Bevacizumab used previous chemotherapy 24. Pregnant women, possibly pregnant women, wishing to become pregnant, and nursing mothers 25. Other conditions not suitable for this study
研究者
相似试验
已完成
2 期
Safety and efficacy of preoperative chemotherapy with SOX+Cetuximab in patients with liver-only metastases(H2,H3), KRAS-WT from colorectal cancer(KSCC1002)Patients with liver-only metastases from colorectal cancerJPRN-UMIN000004331Kyushu Study group of Clinical Cancer32
尚未招募
不适用
A phase II trial of preoperative chemotherapy with capecitabine plus short-course radiotherapy for resectable T3 rectal cancerJPRN-UMIN000016518Meiwa Hospital60
招募中
不适用
Feasibility study of perioperative chemotherapy with neoadjuvant GEM+CDDP and adjuvant S-1 for biliary tract cancerBiliary tract cancerJPRN-UMIN000021206Keio University School of Medicine30
已完成
不适用
Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility multicenter study(1) breast cancer with histological confirmation(2) stage II or III breast cancer and previous standard anthracycline and/or taxane-based PSC, followed by curative surgery(3) age 20-75 years(4) Eastern Cooperative Oncology Group performance status 0,1(5) adequate gastrointestinal function(6) adequate organ functionJPRN-UMIN000013469Saitama Medical University International Medical Center40
已完成
2 期
Efficacy and safety of neoadjuvant chemotherapy by S-1 plus cisplatin for Stage III esophageal squamous cell carcinoma: A phase II trialEsophageal squamous cell carcinomaJPRN-UMIN000014707agoya University Hospital30